Alyeska Investment Group
ABMD

Alyeska Investment Group’s Abiomed Inc ABMD Stock Holding History

Alyeska Investment Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-237,857
Closed -$58.4M – 542
2022
Q3 		$58.4M Buy
+237,857
New +$64.2M 0.68% 39
2019
Q1 		– Sell
-33,202
Closed -$10.8M – 469
2018
Q4 		$10.8M Buy
+33,202
New +$11.5M 0.16% 162
2018
Q1 		– Sell
-82,551
Closed -$15.5M – 533
2017
Q4 		$15.5M Sell
82,551
-37,596
-31% -$7.02M 0.12% 185
2017
Q3 		$20.3M Buy
120,147
+51,253
+74% +$7.75M 0.15% 182
2017
Q2 		$9.87M Sell
68,894
-11,106
-14% -$1.49M 0.08% 241
2017
Q1 		$10M Buy
+80,000
New +$9.27M 0.08% 255

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Alyeska Investment Group's ABMD Position: Q4 2022 in Review

Alyeska Investment Group sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 237,857 shares — an estimated $58.4M sold.

Alyeska Investment Group first reported a position in ABMD in Q1 2017 and held it in 6 quarters. The position peaked at $58.4M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Alyeska Investment Group reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Alyeska Investment Group sold 237,857 Abiomed Inc shares in Q4 2022, an estimated $58.4M.
  • Alyeska Investment Group first reported a position in Abiomed Inc in Q1 2017 and held it in 6 quarters.
  • Alyeska Investment Group's Abiomed Inc position peaked at $58.4M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Alyeska Investment Group's 13F filing for Q4 2022, filed 14 Feb 2023.